Accent Capital Management’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.33K Buy
508
+168
+49% +$688 ﹤0.01% 206
2025
Q4
$7.36K Buy
340
+190
+127% +$1.63K ﹤0.01% 235
2025
Q3
$4.06K Hold
150
﹤0.01% 341
2025
Q2
$3.64K Buy
+150
New +$2.34K ﹤0.01% 356

Other funds holding OM

Accent Capital Management's OM Position: Q1 2026 in Review

Accent Capital Management increased its Outset Medical (OM) stake by 49% in Q1 2026, buying an estimated $688 and bringing the position to 508 shares worth $9.33K. The position accounts for ﹤0.01% of the portfolio, ranked #206.

Accent Capital Management first reported a position in OM in Q2 2025 and has held it in 4 quarters since. 99 funds tracked by Wall St. Rank hold OM as of Q1 2026.

  • Accent Capital Management held 508 shares of Outset Medical worth $9.33K as of Q1 2026.
  • Accent Capital Management bought 168 Outset Medical shares in Q1 2026, an estimated $688.
  • Outset Medical made up ﹤0.01% of Accent Capital Management's portfolio in Q1 2026, its #206 holding.
  • Accent Capital Management first reported a position in Outset Medical in Q2 2025 and has held it in 4 quarters since.
  • 99 funds tracked by Wall St. Rank held Outset Medical as of Q1 2026.

Based on Accent Capital Management's 13F filing for Q1 2026, filed 11 May 2026.